Management of immunotherapy toxicity in gynecological cancers

Management of immunotherapy toxicity in gynecological cancers

VJOncology

1 year
522 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Physicians who are dealing with gynecological tumors have a limited experience of how to deal with the complications and toxicity associated with immunotherapy, suggests Alexandra Leary, MD, PhD, of the Gustave Roussy Institute of Oncology, Paris, France. To resolve this, Dr Leary suggests an interdisciplinary network comprised of consultants with more substantial experience within the field of immunotherapy, such as lung cancer specialists. She notes the substantial differences between the toxicity profiles of chemo and immunotherapies, with immunotherapy toxicity having the potential to be severe, sudden and life-threatening. Thus, it is essential for physicians to liaise, as well as to reiterate the benefit immunotherapy has over potential risk. This was explored at the UK Oncology Forum (OF) 2018, held in Liverpool, UK.
Up Next Autoplay
Phase I/II Study of Ruxolitinib @SeattleCCA @heidigraydrezn5 @UWashOBGYN
Phase I/II Study of Ruxolitinib @SeattleCCA @heidigraydrezn5 @UWashOBGYN
Category: Ovarian Cancer
21 Views
SeattleCCA 4 days
Metformin: How Does This Affect Treatment?
Metformin: How Does This Affect Treatment?
Category: Ovarian Cancer
13 Views
Cancer-News 3 weeks
New Frontier Possibility for Preventing Ovarian Cancer
New Frontier Possibility for Preventing Ovarian Cancer
Category: Ovarian Cancer
10 Views
Cancer-News 3 weeks
"Wild idea" opens possible new boundaries to ovarian cancer prevention
Category: Ovarian Cancer
9 Views
Cancer-News 3 weeks
Study Finds IUD Use Decreased Risk Of Ovarian Cancer By As Much As 32 Percent
Study Finds IUD Use Decreased Risk Of Ovarian Cancer By As Much As 32 Percent
Category: Ovarian Cancer
9 Views
Cancer-News 1 month
PARP Inhibitor Therapy for Ovarian Cancer: Practical Prescribing and Medication Management
PARP Inhibitor Therapy for Ovarian Cancer: Practical Prescribing and Medication Management
Category: Ovarian Cancer
123 Views
imedex 7 months
Evaluating Clinical Pathways for Ovarian Cancer Treatment and Maintenance Therapy
Evaluating Clinical Pathways for Ovarian Cancer Treatment and Maintenance Therapy
Category: Ovarian Cancer
409 Views
imedex 8 months
The importance of encouraging patients to talk about symptoms
The importance of encouraging patients to talk about symptoms
Category: Ovarian Cancer
101 Views
VJOncology 1 year
Quality of life can impact PFS in ovarian cancer
Quality of life can impact PFS in ovarian cancer
Category: Ovarian Cancer
79 Views
VJOncology 1 year